Details for New Drug Application (NDA): 065047
✉ Email this page to a colleague
The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for 065047
Tradename: | CEFAZOLIN SODIUM |
Applicant: | Hikma Farmaceutica |
Ingredient: | cefazolin sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 065047
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065047 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9262 | 0143-9262-25 | 25 VIAL in 1 CARTON (0143-9262-25) / 3 mL in 1 VIAL (0143-9262-01) |
CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065047 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9923 | 0143-9923-90 | 2.2 mL in 1 VIAL (0143-9923-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Sep 18, 2001 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Sep 18, 2001 | TE: | AP | RLD: | No |
Complete Access Available with Subscription